Lenz Therapeutics Inc (LENZ)

08:55 AM

LENZ Therapeutics Inc. Stock Analysis and ForecastPhenomenal capital appreciation - Autocar Professional

08:55 AM

07:32 AM

All Eyes On LENZWill The Regulatory Catalyst Ignite A Rally Or Sink The Stock? - RTTNews

07:32 AM

Jul 22, 2025

Is LENZ Therapeutics Inc. a good long term investmentFree Stock Market Beginners Guide - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

What drives LENZ Therapeutics Inc. stock priceConsistently high yield - jammulinksnews.com

Jul 22, 2025

Jul 19, 2025

What analysts say about LENZ Therapeutics Inc. stockMarket-beating returns - jammulinksnews.com

Jul 19, 2025

Jul 17, 2025

How LENZ Therapeutics Inc. stock performs during market volatilityStrong Return Daily Alerts - Newser

Jul 17, 2025

Jul 16, 2025

LENZ Therapeutics, Inc. (LENZ) is a Great Momentum Stock: Should You Buy? - Yahoo Finance

Jul 16, 2025

Jul 16, 2025

what makes lenz therapeutics inc. stock price move sharplyVolume Spike Monitors - newser.com

Jul 16, 2025

Jul 15, 2025

What makes LENZ Therapeutics Inc. stock price move sharplyFree Smart Money Group - Newser

Jul 15, 2025

Jul 15, 2025

Why LENZ Therapeutics Inc. stock attracts strong analyst attentionReliable High Profit Alerts - Newser

Jul 15, 2025

Jul 15, 2025

Does LENZ Therapeutics, Inc. (LENZ) Have the Potential to Rally 30.86% as Wall Street Analysts Expect? - Yahoo Finance

Jul 15, 2025

Jul 14, 2025

Versant funds sell $6.5 million in Lenz Therapeutics (LENZ) - Investing.com Australia

Jul 14, 2025

Jul 14, 2025

Versant funds sell $6.5 million in Lenz Therapeutics (LENZ) By Investing.com - Investing.com South Africa

Jul 14, 2025

Jul 14, 2025

Leerink Partnrs Has Bearish Outlook for LENZ FY2028 Earnings - Defense World

Jul 14, 2025

Jul 13, 2025

William Blair Maintains LENZ Therapeutics(LENZ.US) With Buy Rating - 富途牛牛

Jul 13, 2025

Jul 11, 2025

LENZ Therapeutics Shares Soar 4.93% on Strategic Partnership, Regulatory Milestone - AInvest

Jul 11, 2025

Jul 09, 2025

LENZ Therapeutics and Laboratoires Théa Announce Exclusive License and Commercialization Agreement for LNZ100 in Canada - VisionMonday.com

Jul 09, 2025

Jul 09, 2025

LENZ and Théa partner on Canadian commercialization of presbyopia eye drop - Eyes On Eyecare

Jul 09, 2025

Jul 08, 2025

LENZ Therapeutics and Laboratoires Théa partner to commercialize LNZ100 for presbyopia in Canada - Ophthalmology Times

Jul 08, 2025

Jul 07, 2025

Lenz Therapeutics stock gains as William Blair reiterates Outperform By Investing.com - Investing.com Nigeria

Jul 07, 2025

Jul 07, 2025

Lenz Therapeutics stock gains as William Blair reiterates Outperform - Investing.com

Jul 07, 2025

Jul 07, 2025

LENZ and Théa ink $70 million licensing deal for presbyopia treatment - Investing.com India

Jul 07, 2025

Jul 07, 2025

LENZ Therapeutics and Laboratoires Théa Announce Exclusive - GlobeNewswire

Jul 07, 2025

Jul 07, 2025

$70M Licensing Deal: LENZ Eyes Canadian Market with Breakthrough Presbyopia Treatment - Stock Titan

Jul 07, 2025

Jul 03, 2025

LENZ Therapeutics: A Pivotal Moment for Presbyopia and Potentially Transformative Returns - AInvest

Jul 03, 2025

Jul 01, 2025

LENZ Therapeutics: Presbyopia Eyedrops Look Promising (NASDAQ:LENZ) - Seeking Alpha

Jul 01, 2025

Jun 30, 2025

LENZ Therapeutics, Inc.(NasdaqGS: LENZ) dropped from Russell Microcap Value Index - MarketScreener

Jun 30, 2025

Jun 16, 2025

LENZ Therapeutics: Ready To Test Its Potential (NASDAQ:LENZ) - Seeking Alpha

Jun 16, 2025

Jun 10, 2025

LENZ Therapeutics reports results of stockholder vote By Investing.com - Investing.com Nigeria

Jun 10, 2025

Jun 10, 2025

LENZ Therapeutics reports results of stockholder vote - Investing.com

Jun 10, 2025

Jun 10, 2025

LENZ Therapeutics Holds 2025 Annual Stockholders Meeting - TipRanks

Jun 10, 2025

Jun 10, 2025

Citi maintains Buy rating, $45 target on LENZ Therapeutics stock By Investing.com - Investing.com South Africa

Jun 10, 2025

Jun 10, 2025

Citi maintains Buy rating, $45 target on LENZ Therapeutics stock - Investing.com

Jun 10, 2025

Jun 10, 2025

Two Sigma Investments LP Has $493,000 Holdings in LENZ Therapeutics, Inc. (NASDAQ:LENZ) - Defense World

Jun 10, 2025

Jun 09, 2025

Transcript : LENZ Therapeutics, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 04 - MarketScreener

Jun 09, 2025